/AI%20(artificial%20intelligence)/Data%20Center%20by%20Caureem%20via%20Shutterstock%20(2).jpg)
Core Scientific (CORZ) shareholders are heading to the polls on Oct. 30 to vote on CoreWeave's (CRWV) $9 billion acquisition bid. According to CNBC's David Faber, the deal is expected to fail, with large institutional holders and activist investors signaling an intent to reject the offer.
The proposed all-stock transaction would give Core Scientific shareholders 0.1235 CoreWeave shares for each share they own, valuing CORZ at roughly $20.40 per share. While that represents a 66% premium to Core Scientific's price before deal talks leaked, many investors believe the company deserves more. Some shareholders are pushing for a valuation closer to $25 per share, or about $11.5 billion total, according to reports from the Financial Times.